VOLTAREN EMULGEL*GEL 120G 1%
- Brand: NOVARTIS FARMA SpA
- Product Code: 034548204
- EAN:
- Availability: In Stock (evaso in 24 ore)
- 3 items
for 13,73€ each - 4 items
for 13,45€ each - 5 items
for 13,17€ each
What it is and what it is used for
Voltaren Emulgel contains the active ingredient diclofenac diethylammonium.
Diclofenac belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs) and is used to reduce pain and inflammation.
Voltaren Emulgel is indicated for the local treatment of painful and inflammatory conditions of a rheumatic or traumatic nature which affect:
- joints, e.g. osteoarthritis and arthritis;
- muscles, e.g. contractures or injuries;
- tendons and ligaments, e.g. tendinitis;
Talk to your doctor if you do not feel better or if you feel worse after 7 days.
What you need to know before taking the medicine
Do not use Voltaren Emulgel:
- if you are allergic to diclofenac diethylammonium or any of the other ingredients of this medicine (listed in section 6);
- if in the past, after taking acetylsalicylic acid or other non-steroidal anti-inflammatory drugs (NSAIDs), you have had an allergic reaction which manifested itself as asthma (difficult breathing caused by inflammation and narrowing of the bronchi), angioedema (swelling of the face, lips, tongue and/or throat with difficulty swallowing and/or breathing), urticaria (itchy skin rash), or acute rhinitis (runny nose due to acute forms of inflammation of the nasal mucosa);
- if you are in the third trimester of pregnancy (see paragraph “Pregnancy, breastfeeding and fertility”);
- if the patient is a child or adolescent under 14 years of age.
Warnings and precautions
Talk to your doctor or pharmacist before using Voltaren Emulgel.
Pay particular attention:
- do not ingest Voltaren Emulgel; after use, in case of contact with the gel, clean your hands with absorbent paper and then wash them (see paragraph 3);
- do not apply Voltaren Emulgel on damaged, diseased or open wound skin;
- avoid allowing Voltaren Emulgel to come into contact with your eyes or mucous membranes, for example in the mouth or vagina. If this occurs, wash the area immediately with running water and contact your doctor;
- do not use Voltaren Emulgel with an occlusive bandage, i.e. covering the affected area with a plastic film that does not allow air to pass through. You can instead use Voltaren Emulgel with gauze that lets air pass;
- if you experience rashes on the skin, stop treatment with Voltaren Emulgel;
- if you use diclofenac on large areas of skin and for long periods of time, you may experience side effects that affect the whole body; do not exceed the recommended dose.
Children and adolescents
Voltaren Emulgel should not be used in children and adolescents under 14 years of age.
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common side effects (may affect up to 1 in 10 people):
- reactions of various types on the skin characterized by rash, skin irritation, redness, itching and swelling (dermatitis, eczema).
Rare side effects (may affect up to 1 in 1,000 people):
- inflammation of the skin with the appearance of blisters (bullous dermatitis).
Very rare side effects (may affect up to 1 in 10,000 people):
- allergic reactions including urticaria;
- angioedema (swelling of the face, lips, tongue and/or throat with difficulty swallowing and/or breathing);
- rash on the skin with the appearance of pustules;
- asthma (difficult breathing caused by inflammation and narrowing of the bronchi);
- appearance of spots or redness on the skin following exposure to sunlight or sun lamps.
Side effects with unknown frequency:
- burning sensation at the application site;
- dry skin.
Reporting of side effects If you get any side effects, talk to your doctor or pharmacist, including any not listed in this leaflet. You can also report side effects directly via the national reporting system at: http://www.aifa.gov.it/content/segnalazioni-reazioni-avverse . By reporting side effects you can help provide more information on the safety of this medicine.